Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,790 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Exposure-toxicity relationships for tipifarnib in cancer patients.
Perez-Ruixo JJ, Chen W, Zhang S, Hayes S, Chow A. Perez-Ruixo JJ, et al. Among authors: hayes s. Br J Clin Pharmacol. 2007 Aug;64(2):219-32. doi: 10.1111/j.1365-2125.2007.02883.x. Epub 2007 Mar 22. Br J Clin Pharmacol. 2007. PMID: 17378913 Free PMC article. Clinical Trial.
Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with BRAF V600-mutant tumours.
Nebot N, Arkenau HT, Infante JR, Chandler JC, Weickhardt A, Lickliter JD, Sarantopoulos J, Gordon MS, Mak G, St-Pierre A, Tang L, Mookerjee B, Carson SW, Hayes S, Grossmann KF. Nebot N, et al. Among authors: hayes s. Br J Clin Pharmacol. 2018 Apr;84(4):764-775. doi: 10.1111/bcp.13488. Epub 2018 Jan 23. Br J Clin Pharmacol. 2018. PMID: 29243287 Free PMC article. Clinical Trial.
1,790 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page